Marketplace Morning Report for Thursday, April 11, 2013
Episode Teaser Image
Biogen Idec, a Massachusetts-based biotech company, is hoping its new multiple sclerosis drug Tecfidera will eventually bring in the hundreds of millions of dollars it cost to develop -- at least before a generic comes along and copies it. CEO George Scangos discusses his company's development process and pricing strategy. A new report from the research firm IDC says personal computer sales are falling fast all around the world. And in Phoenix, Arizona, new signs of a real estate bubble are emerging.
Listen to more audio from this episode
Water wars heat up in New Mexico. CEO of Biogen Idec discusses high drug costs, a new drug for multiple sclerosis and what's up with pharmaceutical drug names.
Posted In: housing market, housing crisis, real estate, arizona
Phoenix, Arizona, was hit hard during the housing crash. Now the housing market is recovering quickly and home buyers are frustrated. But one expert says that doesn't make a housing bubble.
Posted In: PCs, mobile, windows 8, computer
Personal computer sales fell by 14 percent around the world during the first quarter of this year, according to a new report from the research firm IDC.
Posted In: pharmaceuticals, Health, research and development
Biogen Idec CEO George Scangos discusses his company's new multiple sclerosis drug, pricing strategy, and research process.